This study evaluates the effectiveness of different anti-hypertensive drugs on patients with hypertension and microalbuminuria.
This is a a real world registry study. All patients with hypertension in community hospitals in China will be eligible . Patient demographics, medical history, clinical characteristics, physical examination, laboratory tests (including UCAR, blood routine, urine routine, blood biochemistry, and ECG), antihypertensive drugs (including: ACEI/ ARB, thiazide diuretics, CCB, beta-blockers, alpha-blockers, and other antihypertensive drugs used in real-life clinical practice in other communities.) will be recorded. All patients are anticipated to be followed up for 12-month. Effectiveness of different antihypertensive medications on Urine Albumin-to-Creatinine Ratio (UACR) will be evaluted.
Study Type
OBSERVATIONAL
Enrollment
3,000
Urine Albumin-to-Creatinine Ratio (UCAR)
Differences in UCAR between with ACEI/ARB and without ACEI/ARB
Time frame: 12 months
Combined endpoints: re-admission, cardiovascular events, and all-cause mortality
Differences in Combined endpoints between with ACEI/ARB and without ACEI/ARB
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.